$11.83
▼ $0.09 (-0.8%)
REPL
Replimune Group Inc. Common Stock
Health Care
Investor Score
61C+
Moderate rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
91
Technical
41
Fundamental
38
Growth
50
Fair Value
92
News
50
Quality
48
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.